Showing results (161-170 of 214) with videos related to
Sort By:
Pageof 22
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2011
Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapyTheresa M Schwarz, Simon F Leicht, Tamara Radic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancerShirin Khambata-Ford, Christopher T Harbison, Lowell L Hart, et al.AJNR. American Journal of Neuroradiology|April 6, 2013
Effects of increased image noise on image quality and quantitative interpretation in brain CT perfusionK Juluru, J C Shih, A Raj, et al.Plos One|July 5, 2013
Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue XenograftsPatrick C Hermann, Sara M Trabulo, Bruno Sainz, et al.The Joint Commission Journal on Quality Improvement|April 11, 2001
Use of consumer ratings for quality improvement in behavioral health insurance plansJ A Shaul, S V Eisen, V L Stringfellow, et al.Neurology|April 24, 1999
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's diseaseP J Neumann, R C Hermann, K M Kuntz, et al.Clinical Pharmacology and Therapeutics|November 5, 1999
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functionsT Hartung, W D Doecke, D Bundschuh, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2010
Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularizationJaimy Saif, Theresa M Schwarz, David Y S Chau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099Thomas J Lynch, Taral Patel, Luke Dreisbach, et al.Journal of Medicinal Chemistry|November 16, 2012
Rational design of highly selective spleen tyrosine kinase inhibitorsMatthew C Lucas, David M Goldstein, Johannes C Hermann, et al.Pageof 22